Gujarat Terce Laboratories' Stock Reaches All-Time High, Outperforms Sector by 3.24%
Gujarat Terce Laboratories, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on September 13, 2024. The company has shown consistent growth in the past four days, outperforming the sector by 3.24%. Despite a 'Sell' call from MarketsMojo, the company's stock has seen a remarkable 239.35% increase in the past year.
Gujarat Terce Laboratories, a microcap pharmaceutical company, has been making headlines in the stock market as its stock price reached an all-time high on September 13, 2024. The company's stock has been on an upward trend for the past four days, with a consecutive gain of 15.57% during this period. Today, the stock outperformed the sector by 3.24%, with a new 52-week high of Rs. 71.5.
According to MarketsMOJO, a leading stock market analysis platform, the stock call for Gujarat Terce Laboratories is 'Sell'. However, the company's performance in the past year has been impressive, with a 239.35% increase in its stock price compared to the Sensex's 22.72% growth.
Gujarat Terce Laboratories is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price. The company, which operates in the pharmaceutical and drugs industry, has been gaining attention from investors due to its recent success in the market.
While there has been no mention of investor interest or expert opinions, the company's stock performance speaks for itself. Gujarat Terce Laboratories has shown significant growth in the past year, making it a promising player in the microcap segment of the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
